Learn More
Medchemexpress LLC ERK5-IN-2 | 1888305-96-1 | 99.0% | 50 MG

Supplier: Medchemexpress LLC HY12834150MG
ERK5-IN-2 is an orally active, selective ERK5 inhibitor (IC50s of 0.82 μM for ERK5 and 3 μM for ERK5 MEF2D) that does not interact with the BRD4 bromodomain. It has been shown to suppress tumor xenograft growth and bFGF-driven angiogenesis. This compound exhibits favorable pharmacokinetic properties including low intrinsic clearance and high oral bioavailability.
- Selective ERK5 inhibitor with sub-micromolar IC50s
- Does not interact with the BRD4 bromodomain
- Suppresses tumor xenograft growth
- Suppresses basic fibroblast growth factor (bFGF) driven angiogenesis
- Exhibits low intrinsic clearance and high flux
- Demonstrates low efflux ratio in caco-2 cell permeability assays
- Significantly reduces tumor volumes in animal models
- Features an oral bioavailability of 68%
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.